OpenVSafe by OpenVAERS
Search V-safe

E9M-50059-92436

5 vaccinations 17 coded responses 62 check-ins 17 free-text entries 2 call cases
Sex
—
Age at first dose
41-45
ZIP prefix
925 / CA
Registered
2021-01-28
Relationship
Self
Race
American Indian or Alaska Native
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-28
    Registered in v-safe
  2. 2021-01-28
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-28
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site warmth — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Hot injection site (2-3" diameter" without swelling or redness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  6. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  9. 2021-02-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Wheezing — Feeling: Fair · Joint pains, Muscle or body aches · Be unable to work
    Free text: Mild wheezing at night, morning or easy walking
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-04
    Health check-in — day 7, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  11. 2021-02-11
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-17
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-17
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Apathy — Feeling: Fair · Site: Pain
    Free text: lack of motivation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-24
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-05
    Survey response — day 14, dose 2
    MedDRA: Asthenia, Confusional state, Ear pain, Fatigue, Feeling abnormal, Hypopnoea, Malaise, Pain, Pyrexia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Constant, mild eadache; foggy brain/confusion; fatigue/low energy; labored or shallow breathing; body aches; low grade fever and general malaise.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-10
    Survey response — day 21, dose 2
    MedDRA: Fatigue, Headache, Office visit, Somnolence — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Headache and fatigue. Consulted with neurologist. He prescribed Nortriptyline as he believes I'm experiencing a post-vaccination flare-up. Still can't shake the intense fatigue and sleepiness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-31
    Survey response — day 42, dose 2
    MedDRA: Disturbance in attention, Fatigue, Feeling abnormal, Malaise, Sneezing — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: fogginess, fatigue, poor concentration, sneezing and general malaise
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-29
    Dose 3 — Pfizer-BioNTech
  28. 2021-09-29
    Survey response — day 0, dose 3
    MedDRA: Musculoskeletal stiffness, Pruritus — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school
    Free text: Neck stiffness and itchy hands but no rash.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Redness · Headache
    Adult check-in
  30. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Abdominal pain
    Adult check-in
  31. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness, Abdominal pain
    Adult check-in
  32. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  33. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-13
    Survey response — day 14, dose 3
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Intense headache the last two days
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-10-20
    Survey response — day 21, dose 3
    MedDRA: Headache, Vaccine positive rechallenge — Feeling: Fair · Be unable to do your normal daily activities
    Free text: headache that stays and does not respond to medication. Improved but lingering. Same response with second vaccine.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-10-27
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-11
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-12-29
    Survey response — 3 months, dose 3
    MedDRA: Cough, Nausea — Feeling: Good
    Free text: Dry cough. Nausea.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-03-30
    Dose 4 — Pfizer-BioNTech
  41. 2022-03-30
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-03-30
    Health check-in — day 0, dose 4
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  43. 2022-03-31
    Survey response — days 1–6 daily, dose 4
    MedDRA: Pain — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: stabbing pains
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-04-01
    Survey response — days 1–6 daily, dose 4
    MedDRA: Axillary pain — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Pain under armpits
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-04-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  46. 2022-04-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  47. 2022-04-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  48. 2022-04-06
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  49. 2022-04-13
    Survey response — day 14, dose 4
    MedDRA: Dizziness, Fatigue, Headache, Myalgia, Nausea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Chronic headache, fatigue, dizziness, sore muscles, nausea.
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-04-20
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-04-29
    Survey response — day 28, dose 4
    MedDRA: Palpitations, Syncope — Feeling: Good · Be unable to work or attend school
    Free text: Palpitations, syncope
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-05-04
    Survey response — day 35, dose 4
    MedDRA: Body temperature increased, Confusional state, Palpitations, Respiratory disorder, Syncope — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Heart palpitations, syncope, confusion, breathing problems, 100° fever.
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-05-04
    Report sent to call center — day 35, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  54. 2022-05-05
    Call successful
    Participant prefers to complete VAERS report online
  55. 2022-05-11
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  56. 2022-07-01
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  57. 2022-09-28
    Survey response — 6 months, dose 4
    MedDRA: Asthma, Brain fog, Palpitations, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Heart palpitations, head fogginess, asthma attacks.
    MedDRA releases: 2024-11 · check-in free text available
  58. 2022-09-28
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  59. 2022-09-29
  60. 2022-11-02
    Dose 5 — Pfizer-BioNTech
  61. 2022-11-03
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Diarrhea, Abdominal pain
    Adult check-in
  62. 2022-11-04
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches
    Adult check-in
  63. 2022-11-05
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Itching · Headache, Diarrhea
    Adult check-in
  64. 2022-11-06
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness
    Adult check-in
  65. 2022-11-08
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  66. 2022-11-09
    Health check-in — day 7, dose 5
    Feeling: Good · Headache
    Adult check-in
  67. 2022-11-25
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  68. 2022-11-30
    Survey response — day 28, dose 5
    MedDRA: Headache, Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activities
    Free text: intense headaches, sore throat
    MedDRA releases: 2024-11 · check-in free text available
  69. 2022-12-07
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  70. 2022-12-14
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  71. 2023-02-01
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  72. 2023-05-03
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Pfizer-BioNTech
22021-02-17Pfizer-BioNTech
32021-09-29Pfizer-BioNTech No
42022-03-30Pfizer-BioNTech No
52022-11-02Pfizer-BioNTech No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-01-29

Systemic reaction (other): Hot injection site (2-3" diameter" without swelling or redness.

2021-02-03

Systemic reaction (other): Mild wheezing at night, morning or easy walking

Release 4 — days 1–6 daily, dose 2

2021-02-18

Systemic reaction (other): lack of motivation

Release 5 — day 14, dose 2

2021-03-05

Symptoms: Constant, mild eadache; foggy brain/confusion; fatigue/low energy; labored or shallow breathing; body aches; low grade fever and general malaise.

Release 5 — day 21, dose 2

2021-03-10

Symptoms: Headache and fatigue. Consulted with neurologist. He prescribed Nortriptyline as he believes I'm experiencing a post-vaccination flare-up. Still can't shake the intense fatigue and sleepiness.

Release 6 — day 42, dose 2

2021-03-31

Symptoms: fogginess, fatigue, poor concentration, sneezing and general malaise

Release 9 — day 0, dose 3

2021-09-29

Systemic reaction (other): Neck stiffness and itchy hands but no rash.

Release 10 — day 14, dose 3

2021-10-13

Symptoms: Intense headache the last two days

Release 10 — day 21, dose 3

2021-10-20

Symptoms: headache that stays and does not respond to medication. Improved but lingering. Same response with second vaccine.

Release 10 — 3 months, dose 3

2021-12-29

Symptoms: Dry cough. Nausea.

Release 11 — days 1–6 daily, dose 4

2022-03-31

Systemic reaction (other): stabbing pains

2022-04-01

Systemic reaction (other): Pain under armpits

Release 11 — day 14, dose 4

2022-04-13

Symptoms: Chronic headache, fatigue, dizziness, sore muscles, nausea.

Release 11 — day 28, dose 4

2022-04-29

Symptoms: Palpitations, syncope

Release 11 — day 35, dose 4

2022-05-04

Symptoms: Heart palpitations, syncope, confusion, breathing problems, 100° fever.

Release 12 — 6 months, dose 4

2022-09-28

Symptoms: Heart palpitations, head fogginess, asthma attacks.

Release 12 — day 28, dose 5

2022-11-30

Symptoms: intense headaches, sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia ✓ ✓ ✓
SDAsthma · · ✓
SDBody temperature increased · · ✓
SDBrain fog · · ✓
SDConfusional state ✓ ✓ ✓
SDCough · · ✓
SDDisturbance in attention ✓ ✓ ✓
SDDizziness · · ✓
SDEar pain ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFeeling abnormal ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypopnoea ✓ ✓ ✓
SDMalaise ✓ ✓ ✓
SDMyalgia · · ✓
SDNausea · · ✓
SDOffice visit ✓ ✓ ✓
SDOropharyngeal pain · · ✓
SDPain ✓ ✓ ✓
SDPalpitations · · ✓
SDPre-existing disease · · ✓
SDPyrexia ✓ ✓ ✓
SDRespiratory disorder · · ✓
SDSneezing ✓ ✓ ✓
SDSomnolence ✓ ✓ ✓
SDSyncope · · ✓
SDVaccine positive rechallenge · · ✓
SROApathy ✓ ✓ ✓
SROAxillary pain · · ✓
SROInjection site warmth ✓ ✓ ✓
SROMusculoskeletal stiffness · · ✓
SROPain · · ✓
SROPruritus · · ✓
SROWheezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release